The movement toward transparency is global, touching almost every aspect of society. Whether the topic is NSA eavesdropping in the U.S. or banking practices in the European Union, transparency and accountability go hand in hand. The pharma industry is no different.
The head of the Food and Drug Administration says her agency will add more inspectors in India...
The manipulation of clinical research data for a blood pressure drug sold by Novartis Pharma K.K...
Tokyo prosecutors raided Novartis Pharma K.K. on Wednesday over its alleged use of exaggerated...
Merck and Samsung Bioepis Co., Ltd., announced today that they have expanded their collaboration with an agreement to develop, manufacture and commercialize MK-1293, an insulin glargine candidate for the treatment of patients with type 1 and type 2 diabetes.
AbbVie has announcesd a US$320 million [approximately S$400 million] investment to establish operations in Singapore for small molecule and biologics active drug substance manufacturing.
Today, the U.S. Food and Drug Administration announced that Commissioner Margaret A. Hamburg, M.D. will travel Feb. 10-18 to India to further strengthen cooperation between the FDA and its Indian regulatory counterparts.
GlaxoSmithKline says fourth-quarter earnings nearly tripled and sales rose 5 percent, even as an ongoing investigation hurt business in China.
Authorities in eastern China announced a ban Tuesday on live poultry sales following a spike in the number of people infected with the H7N9 strain of bird flu, with the busy Chinese New Year travel period already under way.
Actavis plc has signed and completed an agreement for Zhejiang Chiral Medicine Chemicals Co., Ltd to acquire Actavis' interest in Actavis (Foshan) Pharmaceuticals Co., Ltd., an Actavis subsidiary based in Foshan, China.
U.S. health regulators said Thursday they are barring imported drugs from an overseas factory operated by Ranbaxy Laboratories, India's largest drugmaker, due to quality control violations.
A spate of bird flu cases since the beginning of the year in China has experts watching closely as millions of people and poultry are on the move ahead of the Lunar New Year holiday, the world's largest annual human migration. China has reported more than 50 H7N9 infections in 2014 after the strain jumped from birds to people for the first time last year.
As we move into 2014 the global pharmaceutical market can breathe a sigh of relief that the worst seems to be behind us. The hit to the marketplace due to patent expiry reached its peak in 2012 when approximately $38 billion in revenue evaporated.
The World Health Organization is set to announce today that India has officially eliminated polio.
The U.S. Pharmacopeial Convention (USP), a nonprofit global health organization that creates and promotes quality standards for medicines, herbal medicines/dietary supplements and food ingredients, today marked the official inauguration of its expanded state-of-the-art laboratory and administrative facility in Shanghai, China.
China's biggest drug distributor says two former executives are the target of a corruption investigation, widening a graft probe that has focused on foreign pharmaceutical makers. A former vice president of state-owned Sinopharm Group Ltd., Shi Jinming, was detained last week by Shanghai...
Japan's health ministry said Thursday it has filed a criminal complaint against Novartis Pharma, alleging exaggerated advertising for the heart condition and blood-pressure lowering drug Diovan. Novartis Pharma K.K., the local unit of Swiss pharmaceutical group Novartis AG, issued an apology on...
The Japanese health ministry is making final arrangements to file a criminal complaint with prosecutors against Novartis Pharma K.K. over alleged exaggerated advertising for a blood pressure-lowering drug.
Vaccines did not cause the deaths of nine children shortly after they were inoculated for hepatitis in a Chinese government program and no links have been found in eight other cases still being investigated, health officials said Friday after safety concerns arose.
Chinese authorities said Wednesday that a 73-year-old Chinese woman died after being infected with a bird flu strain that had sickened a human for the first time, a development that the World Health Organization called "worrisome."
ScinoPharm today announced that the company has completed construction of its Changshu plant on a 16-acre site. The facilities, located in Changshu, (Jiangsu province) China, include an R&D process development center and a multipurpose API (active pharmaceutical ingredients) manufacturing plant fully compliant with U.S., EU, and Chinese CGMP standards.
The United States and 11 other nations negotiating a free trade zone stretching from Chile to Japan failed to reach a final agreement at talks in Singapore, but indicated they were closing in on a landmark deal.
Hong Kong reported its second human case of H7N9 bird flu just days after the first, raising fears that the virus is spreading beyond mainland China. The Health Department said late Friday that an 80-year-old man being treated for a chronic illness in the hospital was found to have the bird flu strain.
Hong Kong is on public-health alert after the city confirmed its first human case of the deadly H7N9 bird flu.
Our annual reader survey looks at issues facing innovator companies and the CMO/CSOs that support them.
As part of the realignment, Harvard Bioscience will reduce its global workforce by approximately 13 percent by eliminating certain operational redundancies across several sites, creating a leaner, more nimble organization. It plans to reinvest some of the savings into its China expansion, sales and marketing and product development initiatives, in order to drive growth.
JHL Biotech, Inc., a provider of biopharmaceutical process development and manufacturing services, and Switzerland-based Selexis SA, a provider of technologies for mammalian cell line development, announced today that they have signed a non-exclusive strategic agreement to provide biopharmaceutical customers a seamless solution for the development and cGMP manufacturing of biologic drugs.
Hong Kong has reported its first case of the H7N9 bird flu strain, in a possible sign the virus is spreading beyond mainland China since it first emerged there earlier this year. H7N9 was first identified April. It has sickened 139 people and killed 45 in China and Taiwan.
Who are the technical innovators in the US? The image we often have is that of the young Silicon Valley geek or the surfing California biopharma scientist -- sometimes brash and unafraid to challenge authority and champion new and better ideas.
- Page 1